reboxetine has been researched along with pnu-282987 in 1 studies
Studies (reboxetine) | Trials (reboxetine) | Recent Studies (post-2010) (reboxetine) | Studies (pnu-282987) | Trials (pnu-282987) | Recent Studies (post-2010) (pnu-282987) |
---|---|---|---|---|---|
626 | 193 | 184 | 146 | 0 | 123 |
Protein | Taxonomy | reboxetine (IC50) | pnu-282987 (IC50) |
---|---|---|---|
5-hydroxytryptamine receptor 3A | Rattus norvegicus (Norway rat) | 4.541 | |
5-hydroxytryptamine receptor 3B | Rattus norvegicus (Norway rat) | 4.541 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andreasen, JT; Christensen, JK; Mirza, NR; Nielsen, EØ; Olsen, GM; Peters, D; Redrobe, JP | 1 |
1 other study(ies) available for reboxetine and pnu-282987
Article | Year |
---|---|
Subtype-selective nicotinic acetylcholine receptor agonists enhance the responsiveness to citalopram and reboxetine in the mouse forced swim test.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Antidepressive Agents; Azepines; Benzamides; Bridged Bicyclo Compounds; Citalopram; Female; Male; Mice; Morpholines; Motor Activity; Nicotinic Agonists; Pyridines; Rats; Rats, Wistar; Reboxetine; Receptors, Nicotinic; Swimming; Xenopus laevis | 2011 |